LncRNA H19 ameliorates myocardial ischemia-reperfusion injury by targeting miR-22-3P

Int J Cardiol. 2019 Mar 1:278:224. doi: 10.1016/j.ijcard.2018.11.017.

¹ Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, 430060, Hubei Province, China.
² Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, 430060, Hubei Province, China. Electronic address: chenjing821111@163.com.
³ Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, 430060, Hubei Province, China. Electronic address: hong-jiang@whu.edu.cn.

No abstract available

Keywords: LncRNA H19; Myocardial ischemia-reperfusion injury; miR-22-3P.

Publication types